Genentech Inc.

02/15/2026 | Press release | Distributed by Public on 02/16/2026 00:06

Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Genentech Inc. published this content on February 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 16, 2026 at 06:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]